BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16823686)

  • 1. [Effectiveness of typical and atypical neuroleptics in the control of behavioral and psychopathological symptoms of dementia. Results of a retrospective study].
    Martin Carrasco M; Ballesteros J; Bulbena A; Baraibar G; García C; Minguez L; Blanco J; de Blas J; Agüero JA; Ibarra N
    Actas Esp Psiquiatr; 2006; 34(4):251-6. PubMed ID: 16823686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
    Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia.
    Suh GH; Greenspan AJ; Choi SK
    Int J Geriatr Psychiatry; 2006 Jul; 21(7):654-60. PubMed ID: 16821257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral and psychological symptoms in dementia: the role of atypical antipsychotics.
    Lawlor BA
    J Clin Psychiatry; 2004; 65 Suppl 11():5-10. PubMed ID: 15264965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study.
    Paleacu D; Barak Y; Mirecky I; Mazeh D
    Int J Geriatr Psychiatry; 2008 Apr; 23(4):393-400. PubMed ID: 17879256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic strategies for behavioral and psychological symptoms (BPSD) in demented patients.
    Torta R; Badino E; Scalabrino A
    Arch Gerontol Geriatr Suppl; 2004; (9):443-54. PubMed ID: 15207446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ["Judicious" use of neuroleptic drugs in the treatment of behavioral symptoms in the course of Alzheimer disease].
    Riva E; Nobili A; Trecate F
    Recenti Prog Med; 1998 Nov; 89(11):598-603. PubMed ID: 9844448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical antipsychotics in the management of behavioral symptoms associated with dementia.
    González-Concepción JJ; Geil K; Jiménez-Velázquez IZ; Ramos-Romey C
    Bol Asoc Med P R; 2009; 101(1):51-3. PubMed ID: 19954089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recognition and treatment of behavioral and psychological symptoms of dementias: lessons from the CATIE-AD study].
    Kálmán J; Kálmán S; Pákáski M
    Neuropsychopharmacol Hung; 2008 Oct; 10(4):233-49. PubMed ID: 19213202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral and psychological symptoms assessed with the BEHAVE-AD-FW are differentially associated with cognitive dysfunction in Alzheimer's disease.
    Ito T; Meguro K; Akanuma K; Meguro M; Lee E; Kasuya M; Ishii H; Mori E
    J Clin Neurosci; 2007 Sep; 14(9):850-5. PubMed ID: 17587584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Trazodone for the treatment of behavioral and psychological symptoms of dementia (BPSD) in Alzheimer's disease: a retrospective study focused on the aggression and negativism in caregiving situations].
    Kitamura Y; Kudo Y; Imamura T
    No To Shinkei; 2006 Jun; 58(6):483-8. PubMed ID: 16856516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New therapeutic strategies for behavioral and psychological symptoms of dementia].
    Ikeda M
    Rinsho Shinkeigaku; 2005 Nov; 45(11):861-3. PubMed ID: 16447746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of yokukansan on the behavioral and psychological symptoms of dementia in elderly patients with Alzheimer's disease.
    Monji A; Takita M; Samejima T; Takaishi T; Hashimoto K; Matsunaga H; Oda M; Sumida Y; Mizoguchi Y; Kato T; Horikawa H; Kanba S
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):308-11. PubMed ID: 19138715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changeover to risperidone after treatment with conventional low potency neuroleptics in dementia patients. An observation study during usage].
    Stoppe G; Schreiner A; Schmitt AB
    Dtsch Med Wochenschr; 2006 Mar; 131(9):423-9. PubMed ID: 16493564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality in elderly dementia patients treated with risperidone.
    Haupt M; Cruz-Jentoft A; Jeste D
    J Clin Psychopharmacol; 2006 Dec; 26(6):566-70. PubMed ID: 17110812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of music therapy in the treatment of behavioral and psychiatric symptoms of dementia.
    Raglio A; Bellelli G; Traficante D; Gianotti M; Ubezio MC; Villani D; Trabucchi M
    Alzheimer Dis Assoc Disord; 2008; 22(2):158-62. PubMed ID: 18525288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amisulpride versus risperidone treatment for behavioral and psychological symptoms in patients with dementia of the Alzheimer type: a randomized, open, prospective study.
    Lim HK; Pae CU; Lee C; Lee CU
    Neuropsychobiology; 2006; 54(4):247-51. PubMed ID: 17356308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Management of behavioral disorders in dementia patients].
    Lebert F; Robert P; Rigaud AS
    Rev Neurol (Paris); 2000 Sep; 156(8-9):767-72. PubMed ID: 10992121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drugs used to relieve behavioral symptoms in people with dementia or an unacceptable chemical cosh? Argument.
    Ballard C; Cream J
    Int Psychogeriatr; 2005 Mar; 17(1):4-12; discussion 22-9. PubMed ID: 15945588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia.
    Suh GH; Greenspan AJ; Choi SK
    Int J Geriatr Psychiatry; 2007 May; 22(5):494-5. PubMed ID: 17471597
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.